IQVIA Holdings Inc. (IQV) shares surged 7.57% in pre-market trading on Tuesday following the release of its better-than-expected second-quarter 2025 financial results and positive full-year guidance.
The healthcare data and analytics company reported adjusted earnings per share (EPS) of $2.81, surpassing the analyst consensus estimate of $2.77. Revenue for the quarter came in at $4.02 billion, also beating the expected $3.96 billion. The company's net income for the quarter stood at $266 million.
IQVIA's strong performance and optimistic outlook have boosted investor confidence. The company provided upbeat full-year 2025 guidance, projecting revenue between $16.1 billion and $16.3 billion, and adjusted EBITDA in the range of $3.75 billion to $3.825 billion. The adjusted EPS forecast for the full year is set between $11.75 and $12.05, indicating continued growth expectations. This positive outlook, coupled with the Q2 earnings beat, appears to be the primary driver behind the significant pre-market stock movement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.